Nov 14, 2023 / 08:00AM GMT
Brian Gil Tanquilut - Jefferies LLC, Research Division - Senior Equity/Stock Analyst
Good morning, and welcome to the 2023 Jefferies Global Healthcare Conference. Thank you, everyone, for coming. We really appreciate you being here. I'm Brian Tanquilut, health care services analyst U.S. based for Jefferies. And with us today is McKesson and Britt Vitalone, the company's CFO. I don't know if you guys are familiar with McKesson, but Britt, maybe -- well we'll start with the fact that I think a lot of investors view you guys as a drug distributor.
And I think the business has evolved over time, and you do more than that today. So if we can walk through just an intro and what's going on with McKesson for the benefit of the audience listening here today.
Britt J. Vitalone - McKesson Corporation - Executive VP & CFO
Sure. Well, first of all, thank you for hosting us. Good morning. So McKesson is organized in 4 segments. We have our U.S. Pharmaceutical segment, which is our traditional U.S. drug distribution segment. We service hospitals,
Mckesson Corp at Jefferies London Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers